B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CD163 mediating an anti-inflammatory response

REACTOME PATHWAY
Reactome: R-HSA-96628345 genes18 compounds

The CD163 mediating an anti-inflammatory response pathway (Reactome ID: R-HSA-9662834) involves 5 genes and is affected by 18 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

ADAM17FURINIL6MAPK14PLK2

Compounds Affecting CD163 mediating an anti-inflammatory response

#CompoundTargets HitStudies
1Prednisolone1,000
2Sorafenib300
3Dasatinib299
4Afatinib297
5egcg300
6fisetin78
7myricetin-3-O-galactopyranoside [Supplementary Concept]300
8Quercetin300
9Anisomycin247
10Celecoxib295
11isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from300
12tyrphostin ag 14784
13withaferin300
14Bisphenol A-Glycidyl Methacrylate197
15Kaempferols300
16Diminazene300
17silver sulfadiazine299
18Wortmannin300

About the CD163 mediating an anti-inflammatory response Pathway

The CD163 mediating an anti-inflammatory response pathway is catalogued in Reactome (ID: R-HSA-9662834) and involves 5 genes. In the BiohacksAI corpus, 18 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include ADAM17, FURIN, IL6, MAPK14, PLK2.